Search Results Search Sort by RelevanceMost Recent Case and Commentary Dec 2019 Using the 4-S Framework to Guide Conversations With Patients About CRISPR Lisa S. Lehmann, MD, PhD, MSc Empathic communication skills help motivate understanding of safety, significance of harms, impact on succeeding generations, and social consequences. AMA J Ethics. 2019;21(12):E1029-1035. doi: 10.1001/amajethics.2019.1029. Case and Commentary Dec 2019 How Should “CRISPRed” Babies Be Monitored Over Their Life Course to Promote Health Equity? Charis Thompson, PhD Transnational monitoring efforts should focus on safety, defining standard of care, and promoting just access to innovation. AMA J Ethics. 2019;21(12):E1036-1041. doi: 10.1001/amajethics.2019.1036. Viewpoint Jan 2017 Should US Physicians Support the Decriminalization of Commercial Sex? Emily F. Rothman, ScD The Nordic model policy option for addressing commercial sex—which exempts sellers from criminal penalties—offers several potential advantages. AMA J Ethics. 2017;19(1):110-121. doi: 10.1001/journalofethics.2017.19.1.sect1-1701. Viewpoint Jan 2017 Decreasing Human Trafficking through Sex Work Decriminalization Erin Albright, JD and Kate D'Adamo, MA Decriminalization of the sex trade speaks to medical ethics by reducing sex workers’ vulnerability to violence, exploitation, stigma, and trafficking. AMA J Ethics. 2017;19(1):122-126. doi: 10.1001/journalofethics.2017.19.1.sect2-1701. Letter to the Editor Sep 2006 Commercial Labs Offer High Quality Services Herman Hurwitz, MD Virtual Mentor. 2006;8(9):C1-C3. doi: 10.1001/virtualmentor.2006.8.9.corr1-0609. Case and Commentary Aug 2006 Dermatology Lab Referrals: Cash Cow or Ethical Trap? Jane M. Grant-Kels, MD and Barry D. Kels, MD, JD Virtual Mentor. 2006;8(8):499-502. doi: 10.1001/virtualmentor.2006.8.8.ccas2-0608. Case and Commentary Aug 2006 Dispensing Cosmeceuticals from the Office Michael H. Gold, MD Virtual Mentor. 2006;8(8):503-508. doi: 10.1001/virtualmentor.2006.8.8.ccas1-0608. Case and Commentary Sep 2007 Assisted Reproduction and Primum Non Nocere Marta Kolthoff, MD Virtual Mentor. 2007;9(9):605-610. doi: 10.1001/virtualmentor.2007.9.9.ccas2-0709. Case and Commentary Jun 2007 Sex Selection for Nonmedical Reasons Louise P. King, MD, JD Virtual Mentor. 2007;9(6):418-422. doi: 10.1001/virtualmentor.2007.9.6.ccas3-0706. Health Law Feb 2009 When Patient-Physician Confidentiality Conflicts with the Law Kristin E. Schleiter, JD Virtual Mentor. 2009;11(2):146-148. doi: 10.1001/virtualmentor.2009.11.2.hlaw1-0902. Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
Case and Commentary Dec 2019 Using the 4-S Framework to Guide Conversations With Patients About CRISPR Lisa S. Lehmann, MD, PhD, MSc Empathic communication skills help motivate understanding of safety, significance of harms, impact on succeeding generations, and social consequences. AMA J Ethics. 2019;21(12):E1029-1035. doi: 10.1001/amajethics.2019.1029.
Case and Commentary Dec 2019 How Should “CRISPRed” Babies Be Monitored Over Their Life Course to Promote Health Equity? Charis Thompson, PhD Transnational monitoring efforts should focus on safety, defining standard of care, and promoting just access to innovation. AMA J Ethics. 2019;21(12):E1036-1041. doi: 10.1001/amajethics.2019.1036.
Viewpoint Jan 2017 Should US Physicians Support the Decriminalization of Commercial Sex? Emily F. Rothman, ScD The Nordic model policy option for addressing commercial sex—which exempts sellers from criminal penalties—offers several potential advantages. AMA J Ethics. 2017;19(1):110-121. doi: 10.1001/journalofethics.2017.19.1.sect1-1701.
Viewpoint Jan 2017 Decreasing Human Trafficking through Sex Work Decriminalization Erin Albright, JD and Kate D'Adamo, MA Decriminalization of the sex trade speaks to medical ethics by reducing sex workers’ vulnerability to violence, exploitation, stigma, and trafficking. AMA J Ethics. 2017;19(1):122-126. doi: 10.1001/journalofethics.2017.19.1.sect2-1701.
Letter to the Editor Sep 2006 Commercial Labs Offer High Quality Services Herman Hurwitz, MD Virtual Mentor. 2006;8(9):C1-C3. doi: 10.1001/virtualmentor.2006.8.9.corr1-0609.
Case and Commentary Aug 2006 Dermatology Lab Referrals: Cash Cow or Ethical Trap? Jane M. Grant-Kels, MD and Barry D. Kels, MD, JD Virtual Mentor. 2006;8(8):499-502. doi: 10.1001/virtualmentor.2006.8.8.ccas2-0608.
Case and Commentary Aug 2006 Dispensing Cosmeceuticals from the Office Michael H. Gold, MD Virtual Mentor. 2006;8(8):503-508. doi: 10.1001/virtualmentor.2006.8.8.ccas1-0608.
Case and Commentary Sep 2007 Assisted Reproduction and Primum Non Nocere Marta Kolthoff, MD Virtual Mentor. 2007;9(9):605-610. doi: 10.1001/virtualmentor.2007.9.9.ccas2-0709.
Case and Commentary Jun 2007 Sex Selection for Nonmedical Reasons Louise P. King, MD, JD Virtual Mentor. 2007;9(6):418-422. doi: 10.1001/virtualmentor.2007.9.6.ccas3-0706.
Health Law Feb 2009 When Patient-Physician Confidentiality Conflicts with the Law Kristin E. Schleiter, JD Virtual Mentor. 2009;11(2):146-148. doi: 10.1001/virtualmentor.2009.11.2.hlaw1-0902.